Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 37: 78-82, 1991;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larue, C.
Right arrow Articles by Pau, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larue, C.
Right arrow Articles by Pau, B.

Clinical Chemistry, Vol 37, 78-82, Copyright © 1991 by American Association for Clinical Chemistry

Immunoradiometric assay of myosin heavy chain fragments in plasma for investigation of myocardial infarction

C Larue, C Calzolari, J Leger, J Leger and B Pau
Sanofi Recherche, Montpellier, France.

Estimation of the extent and location of infarct is important for the prognosis and hence therapeutic strategy in patients with acute myocardial infarction (AMI). Because cardiac myosin is the major structural protein of the myocardium, and may thus reflect the extent of injured tissue, we established a new sensitive immunoradiometric assay, using a pair of monoclonal antibodies (Mabs) that specifically bind the myosin heavy chain fragments liberated from the myocyte into plasma after a heart attack. A first Mab is linked to a magnetic solid phase. A second Mab, radiolabeled with 125I, is used to detect myosin trapped on the solid phase by the first Mab during a 3-h incubation. This assay can detect 10 micro-units of myosin per liter and is highly reproducible.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
J. Bleier, K.-P. Vorderwinkler, J. Falkensammer, P. Mair, O. Dapunt, B. Puschendorf, and J. Mair
Different intracellular compartmentations of cardiac troponins and myosin heavy chains: a causal connection to their different early release after myocardial damage
Clin. Chem., September 1, 1998; 44(9): 1912 - 1918.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
S. Sorichter, J. Mair, A. Koller, W. Gebert, D. Rama, C. Calzolari, E. Artner-Dworzak, and B. Puschendorf
Skeletal troponin I as a marker of exercise-induced muscle damage
J Appl Physiol, October 1, 1997; 83(4): 1076 - 1082.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A.-P. Gimenez-Roqueplo, I. Leconte, P. Cohen, D. Simon, T. T. Guyene, Jérôm. Célerier, B. Pau, P. Corvol, E. Clauser, and X. Jeunemaitre
The Natural Mutation Y248C of Human Angiotensinogen Leads to Abnormal Glycosylation and Altered Immunological Recognition of the Protein
J. Biol. Chem., April 19, 1996; 271(16): 9838 - 9844.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
M. Lofberg, R. Tahtela, M. Harkonen, and H. Somer
Myosin Heavy-Chain Fragments and Cardiac Troponins in the Serum in Rhabdomyolysis: Diagnostic Specificity of New Biochemical Markers
Arch Neurol, December 1, 1995; 52(12): 1210 - 1214.
[Abstract] [PDF]

Home page
 Circ. Res.Home page
M. S. F. Clarke, R. W. Caldwell, H. Chiao, K. Miyake, and P. L. McNeil
Contraction-Induced Cell Wounding and Release of Fibroblast Growth Factor in Heart
Circ. Res., June 1, 1995; 76(6): 927 - 934.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Association for Clinical Chemistry.